Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus.

Chak A, Buttar NS, Foster NR, Seisler DK, Marcon NE, Schoen R, Cruz-Correa MR, Falk GW, Sharma P, Hur C, Katzka DA, Rodriguez LM, Richmond E, Sharma AN, Smyrk TC, Mandrekar SJ, Limburg PJ. Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):665-72.e1-4.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Barrett Esophagus
Cell Proliferation
Double-Blind Method
Endoscopy, Digestive System
Esophageal Neoplasms
Female
Humans
Insulin
Male
Metformin
Middle Aged
Placebos
Prospective Studies
Ribosomal Protein S6 Kinases
Young Adult

authors with profiles

Marcia Cruz-Correa

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support